Lupin Pharmaceuticals Inc. vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 4 for Lupin Pharmaceuticals Inc..

Lupin Pharmaceuticals Inc.: 0 warning letters, 4 recalls, 0 approval records, 0 Form 483s.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Side by side

Lupin Pharmaceuticals Inc. — Warning letters0

Philips North America — Warning letters0

Lupin Pharmaceuticals Inc. — Recalls4

Philips North America — Recalls355

Lupin Pharmaceuticals Inc. — Approval records0

Philips North America — Approval records0

Lupin Pharmaceuticals Inc. — Form 483s0

Philips North America — Form 483s0

Timeline

Lupin Pharmaceuticals Inc.

Most recent FDA action: July 8, 2026

Full history →

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Lupin Pharmaceuticals Inc. vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/lupin-pharmaceuticals-inc-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗